A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT02914938. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Three-Arm Study of ME-401 Monotherapy in Subjects With Relapsed/Refractory CLL, SLL, or FL, of ME-401 in Combination With Rituximab in Subjects With Relapsed/Refractory CLL/SLL or B-cell NHL, and of ME-401 in Combination With Zanubrutinib in Subjects With Relapsed/Refractory CLL/SLL or B-cell NHL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Three-Arm Study of ME-401 in Subjects with Relapsed/Refractory CLL/SLL or FL, of ME-401 in Combination with Rituximab in Subjects with Relapsed/Refractory CLL/SLL or B-cell NHL, and of ME-401 in Combination with Zanubrutinib in Subjects with Relapsed/Refractory CLL/SLL or B-cell NHL
Study identification
- NCT ID
- NCT02914938
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 97 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2016 (Type not available)
- Primary completion
- Mar 29, 2023 (Actual)
- Completion
- Mar 29, 2023 (Actual)
- Last update posted
- May 9, 2023
2016 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | — |
| Compassionate Care | Corona | California | 92708 | — |
| Sylvester Comprehensive Cancer Center (Univ of Miami School of Med) | Miami | Florida | 33136 | — |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | — |
| Dana Farber | Boston | Massachusetts | 02215 | — |
| Memorial Sloan Kettering | Basking Ridge | New Jersey | 07920 | — |
| Memorial Sloan Kettering | Middletown | New Jersey | 07748 | — |
| Memorial Sloan Kettering | Montvale | New Jersey | 07645 | — |
| Memorial Sloan Kettering | Commack | New York | 11725 | — |
| Memorial Sloan Kettering | Harrison | New York | 10604 | — |
| NYU Langone Laura & Isaac - Perlmutter Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Stony Brook | Stony Brook | New York | 11794 | — |
| Memorial Sloan Kettering | Uniondale | New York | 11553 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Vanderbilt | Nashville | Tennessee | 37240 | — |
| University of Southwestern Medical Center | Dallas | Texas | 75390 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Swedish Cancer Institute | Edmonds | Washington | 98026 | — |
| Swedish Cancer Institute | Issaquah | Washington | 98029 | — |
| Swedish Cancer Center | Seattle | Washington | 98104 | — |
| Carbone Cancer Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02914938, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2023 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02914938 live on ClinicalTrials.gov.